ZFP36L2 orchestrates stress-adaptive plasticity in regeneration and cancer.

ZFP36L2 is essential for stress-induced dedifferentiation and intestinal regeneration, with its mutation affecting 5-10% of colorectal cancers and influencing metastasis.

• Why it matters: Understanding the molecular mechanisms behind cell-fate reprogramming in cancer and tissue repair is crucial for developing targeted therapies, as phenotypic plasticity enables tumor progression and regeneration.
• What they did: The study used mouse models and human CRC samples to investigate ZFP36L2's role, demonstrating that its loss impairs dedifferentiation, ISC gene expression, and metastasis, while promoting heterogeneous cell states.
• The result: Findings reveal ZFP36L2 as a key stress-responsive molecular switch that promotes phenotypic plasticity and dedifferentiation, offering potential targets for improving cancer treatment and regenerative medicine.